Yield and diagnostic value of stress myocardial perfusion imaging in patients without known coronary artery disease presenting with syncope

Circulation: Cardiovascular Imaging

Volumn 6, Issue 3, 2013, Pages 384-391

  Al Jaroudi, Wael A ^a,b   Alraies, M Chadi ^b   Wazni, Oussama ^b   Cerqueira, Manuel D ^b   Jaber, Wael A ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Appropriateness criteria; Stress MPI; Syncope; Yield

Indexed keywords

ADULT; AORTA STENOSIS; ARTICLE; CARDIAC IMAGING; CORONARY ARTERY DISEASE; CORONARY RISK; DIAGNOSTIC VALUE; EXERCISE TEST; FAINTNESS; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HEART CATHETERIZATION; HEART MUSCLE PERFUSION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMIC STRESS; HIGH RISK POPULATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; STRESS MYOCARDIAL PERFUSION IMAGING; TREADMILL EXERCISE; AGED; ANALYSIS OF VARIANCE; ANGIOCARDIOGRAPHY; APPROPRIATENESS CRITERIA; CARDIAC GATED IMAGING; CHI SQUARE DISTRIBUTION; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAPHY; EVALUATION; HEMODYNAMICS; KAPLAN MEIER METHOD; METHODOLOGY; MIDDLE AGED; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; SEVERITY OF ILLNESS INDEX; STRESS MPI; TIME; UNITED STATES; VERY ELDERLY; YIELD;

DIAGNOSTIC AGENT; VASODILATOR AGENT;

APPROPRIATENESS CRITERIA; STRESS MPI; SYNCOPE; YIELD;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARDIAC CATHETERIZATION; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEMODYNAMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; OHIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNCOPE; TIME FACTORS; VASODILATOR AGENTS;

MLCS; MLOWN;

EID: 84880246134     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.112.000051     Document Type: Article

References (18)

1. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, Pohost GM, Williams KA; American College of Cardiology Foundation Appropriate Use Criteria Task Force; American Society of Nuclear Cardiology; American College of Radiology; American Heart Association; American Society of Echocardiology; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance; Society of Nuclear Medicine. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53:2201-2229.
2. Ward RP, Al-Mallah MH, Grossman GB, Hansen CL, Hendel RC, Kerwin TC, McCallister BD Jr, Mehta R, Polk DM, Tilkemeier PL, Vashist A, Williams KA, Wolinsky DG, Ficaro EP; American Society of Nuclear Cardiology. American Society of Nuclear Cardiology review of the ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI). J Nucl Cardiol. 2007;14:e26-e38. (Pubitemid 350089285)
3. Ascheim DD, Markowitz SM, Lai H, Engelstein ED, Stein KM, Lerman BB. Vasodepressor syncope due to subclinical myocardial ischemia. J Cardiovasc Electrophysiol. 1997;8:215-221. (Pubitemid 27085883)
4. D'Agostino RB, Russell MW, Huse DM, Ellison RC, Silbershatz H, Wilson PW, Hartz SC. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139(pt 1):272-281. (Pubitemid 30090804)
5. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341:1351-1357. (Pubitemid 29503574)
6. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J. 1973;85:546-562.
7. Jetté M, Sidney K, Blümchen G. Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clin Cardiol. 1990;13:555-565. (Pubitemid 20256072)
8. AlJaroudi W, Jaber WA, Grimm RA, Marwick T, Cerqueira MD. Alternative methods for the assessment of mechanical dyssynchrony using phase analysis of gated single photon emission computed tomography myocardial perfusion imaging. Int J Cardiovasc Imaging. 2012;28:1385-1394.
9. AlJaroudi W, Jaber WA, Cerqueira MD. Effect of tracer dose on left ventricular mechanical dyssynchrony indices by phase analysis of gated single photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol. 2012;19:63-72.
10. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138-2147.
11. AlJaroudi W, Alraies M, DiFillipo F, Brunken R, Cerqueira M, Jaber W. Left ventricular mechanical dyssynchrony should be assessed from stress gated positron emission tomography in patients with normal myocardial perfusion. Eur J Nucl Med Mol Img. 2012;39:665-672.
12. Ficaro EP, Lee BC, Kritzman JN, Corbett JR. Corridor4DM: the Michigan method for quantitative nuclear cardiology. J Nucl Cardiol. 2007;14:455-465. (Pubitemid 47163566)
13. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999;34:618-620. (Pubitemid 29436163)
14. Alboni P, Brignole M, Menozzi C, Raviele A, Del Rosso A, Dinelli M, Solano A, Bottoni N. Diagnostic value of history in patients with syncope with or without heart disease. J Am Coll Cardiol. 2001;37:1921-1928. (Pubitemid 32499981)
15. Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore). 1990;69:160-175. (Pubitemid 20190756)
16. Strickberger SA, Benson DW, Biaggioni I, Callans DJ, Cohen MI, Ellenbogen KA, Epstein AE, Friedman P, Goldberger J, Heidenreich PA, Klein GJ, Knight BP, Morillo CA, Myerburg RJ, Sila CA; American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke; Quality of Care and Outcomes Research Interdisciplinary Working Group; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation in collaboration with the Heart Rhythm Society. J Am Coll Cardiol. 2006;47:473-484. (Pubitemid 43063283)
17. Sarasin FP, Louis-Simonet M, Carballo D, Slama S, Rajeswaran A, Metzger JT, Lovis C, Unger PF, Junod AF. Prospective evaluation of patients with syncope: a population-based study. Am J Med. 2001;111:177-184. (Pubitemid 32786944)
18. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Ruiz Granell R, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631-2671.